PVI by disease category
| . | At initial assessment . | At final assessment . | ||
|---|---|---|---|---|
| Diagnosis . | PVI . | PVI score . | PVI . | PVI score . |
| (Continuous; median, IQR) . | (0-6; median, IQR) . | (Continuous; median, IQR) . | (0-6; median, IQR) . | |
| ITP (entire cohort) | 0.5 (−8.1, 8.9) | 3 (1, 5) | 6.4 (−2.9, 10.7) | 4 (2, 5) |
| Definite ITP | 8.9 (5.8, 11.0) | 5 (4, 5) | 11.1 (9.7, 12.7) | 5 (5, 6) |
| Possible ITP | −1.1 (−10.3, 7.3) | 2 (0, 4) | 3.0 (−5.6, 9.0) | 3 (1, 5) |
| Non-immune TCP | −14.3 (−21.7, −4.9) | 0 (0, 2) | −10.5 (−18.8, −1.6) | 0 (0, 2) |
| Splenomegaly | −14.1 (−18.9, −5.6) | 0 (0, 1.5) | −9.8 (−16.6, −2.6) | 1 (0, 2) |
| Liver disease | −8.5 (−10.2, 1.5) | 1 (0, 3) | −0.9 (−4.7, 2.1) | 2 (2, 3) |
| Familial TCP | −11.7 (−17.4, −4.5) | 0 (0, 2) | −7.0 (−12.0, −2.0) | 1 (0, 2) |
| MDS | -1.5 (−11.0, 2.1) | 2 (0.8, 3) | 1.7 (−1.9, 4.4) | 3 (2, 3) |
| . | At initial assessment . | At final assessment . | ||
|---|---|---|---|---|
| Diagnosis . | PVI . | PVI score . | PVI . | PVI score . |
| (Continuous; median, IQR) . | (0-6; median, IQR) . | (Continuous; median, IQR) . | (0-6; median, IQR) . | |
| ITP (entire cohort) | 0.5 (−8.1, 8.9) | 3 (1, 5) | 6.4 (−2.9, 10.7) | 4 (2, 5) |
| Definite ITP | 8.9 (5.8, 11.0) | 5 (4, 5) | 11.1 (9.7, 12.7) | 5 (5, 6) |
| Possible ITP | −1.1 (−10.3, 7.3) | 2 (0, 4) | 3.0 (−5.6, 9.0) | 3 (1, 5) |
| Non-immune TCP | −14.3 (−21.7, −4.9) | 0 (0, 2) | −10.5 (−18.8, −1.6) | 0 (0, 2) |
| Splenomegaly | −14.1 (−18.9, −5.6) | 0 (0, 1.5) | −9.8 (−16.6, −2.6) | 1 (0, 2) |
| Liver disease | −8.5 (−10.2, 1.5) | 1 (0, 3) | −0.9 (−4.7, 2.1) | 2 (2, 3) |
| Familial TCP | −11.7 (−17.4, −4.5) | 0 (0, 2) | −7.0 (−12.0, −2.0) | 1 (0, 2) |
| MDS | -1.5 (−11.0, 2.1) | 2 (0.8, 3) | 1.7 (−1.9, 4.4) | 3 (2, 3) |
PVI scores and associated PVI values: 0 (–∞, –10); 1 (–10, –5); 2 (−5, 0); 3, (0, 5); 4 (5, 8); 5 (8, 12); 6 (12, +∞). Brackets are inclusive of the value limit.
MDS, myelodysplastic syndrome; TCP, thrombocytopenia.